The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shilkina N.P.

Yaroslavl State Medical University, Yaroslavl, Russia

Driazhenkova I.V.

Iaroslavskaia gosudarstvennaia meditsinskaia akademiia

Systemic vasculitides: Diagnostic stages

Authors:

Shilkina N.P., Driazhenkova I.V.

More about the authors

Journal: Therapeutic Archive. 2013;85(4): 39‑42

Read: 17121 times


To cite this article:

Shilkina NP, Driazhenkova IV. Systemic vasculitides: Diagnostic stages. Therapeutic Archive. 2013;85(4):39‑42. (In Russ.)

References:

  1. Nasonov E.L. Perspektivy lecheniya revmaticheskikh boleznei v nachale XXI veka. Ter arkh 2011; 5: 5-9.
  2. Goloeva R.G., Antipova A.V., Amansakhetov R.B. Differentsial'naya diagnostika granulematoza Vegenera i bolezni Bekhcheta. Nauch-prakt revmatol 2008; 4: 79-82.
  3. Buleeva I.M., Dvoretskii L.I. Sindrom Chardzha-Stros. Praktikuyushchii vrach segodnya 2010; 2: 53-59.
  4. Ovcharenko S.I., Shchendrina I.S., Troitskaya M.P. Revmaticheskaya polimialgiya i gigantokletochnyi arteriit. Lech vrach 2011; 7: 29-33.
  5. Bacon P. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005; 352 (4): 330-332.
  6. Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372 (9634): 234-245.
  7. Moiseev S.V., Strizhakov L.A., Ditterle V.E. i dr. Chastota serdechno-sosudistykh zabolevanii u patsientov s sistemnymi vaskulitami. Klin farmakol ter 2011; 20 (3): 30-34.
  8. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscl Thromb Vasc Biol 2005; 25: 1776-1785.
  9. Shoenfeld Y., Gerli R., Dorial A. et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005; 112: 3337-3347.
  10. Abou-Raya A., Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 2006; 5 (5): 331-337.
  11. Shilkina N.P., Dryazhenkova I.V. Sistemnye vaskulity i ateroskleroz. Ter arkh 2007; 3: 84-92.
  12. Krivosheev O.G., Smitienko I.O., Aslanidi I.P., Mukhortova O.V. Stoikaya remissiya aortoarteriita Takasu, indutsirovannaya dlitel'nym lecheniem infliksimabom i podtverzhdennaya povtornoi pozitronno-emissionnoi tomografiei. Ter arkh 2008; 10: 90-93.
  13. Beketova T.V. Perspektivy primeneniya rituksimaba pri vaskulitakh, assotsiirovannykh s antineitrofil'nymi tsitoplazmaticheskimi antitelami. Nauch-prakt revmatol 2010; 4 (pril. 1): 80-90.
  14. Semenkova E.N., Krivosheev O.G., Novikov P.I. i dr. Granulematoz Vegenera tyazhelogo techeniya, uspeshno lechennyi rituksimabom. Ter arkh 2010; 6: 53-55.
  15. Jones R.B., Ferraro A.J., Chaudhry A.N. et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthr Rheum 2009; 60: 2156-2168.
  16. Lovric S., Erdbruegger U., Kumpers P. et al. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-senter experience with 15 patients. Nephrol Dial Transplant 2009; 24: 79-185.
  17. Hunder G.G., Arend W.P., Bloch D.A. et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthr Rheum 1990; 33: 1065-1067.
  18. Shilkina N.P., Poltyrev A.S., Kaufman E.V. i dr. Klassifikatsionnye kriterii sistemnykh vaskulitov. Klin revmatol 1994; 3: 21-26.
  19. Luqmani R.A., Bacon P.A., Moots R.J. et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671-678.
  20. Nasonov E.L., Baranov A.A., Shilkina N.P. Vaskulity i vaskulopatii. Yaroslavl': Verkhnyaya Volga 1999.
  21. Exley A.R., Bacon P.A., Luqmani R.A. et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessement of damage in the systemic vasculitides. Arthr Rheum 1997; 40: 371-380.
  22. Bacon P.A., Moots R.J., Exley A.R. et al. Vital assessement of vasculitis. Clin. Exp Rheum 1995; 13: 275-278.
  23. Aleksandrova E.N., Nasonov E.L. Innovatsionnye tekhnologii v laboratornoi diagnostike revmaticheskikh zabolevanii. Nauch-prakt revmatol 2010; 2: 13-20.
  24. Nasonov E.L., Aleksandrova E.N. Sovremennye tekhnologii i perspektivy laboratornoi diagnostiki revmaticheskikh zabolevanii. Ter arkh 2010; 5: 5-9.
  25. Black S., Kushner I., Samols D. C-reactive protein. J Biol Chem 2004; 47 (6): 487-490.
  26. Du Clos T.W. C-reactive protein as a regulator of autoimmunity and inflammation. Arthr Rheum 2003; 48 (6): 1475-1477.
  27. Strizhakov L.A., Krivosheev O.G., Semenkova E.N. Klinicheskie varianty porazheniya serdtsa pri sistemnykh vaskulitakh. Ter arkh 2008; 5: 5-8.
  28. Hansson G.K. Inflammation, atherosclerosis and coronary artery disease. New Engl J Med 2005; 352: 1685-1695.
  29. Aleksandrova E.N., Novikov A.A., Diatroptov M.E., Nasonov E.L. Podkhod k prognozirovaniyu terapii genno-inzhenernymi biologicheskimi preparatami pri revmatoidnom artrite. Nauch-prakt revmatol 2009; pril. 3: 3-17.
  30. Novikov P.I., Krivosheev O.G., Semenkova E.N. Opyt ispol'zovaniya monoklonal'nykh antitel k retseptoram CD20 (rituksimaba) u bol'nykh s porazheniem pochek pri granulematoze Vegenera. Ter arkh 2011; 11 : 70-76.
  31. Aouba A., Pagnnoux C., Bienvenu B. et al. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin Rev Allergy Immunol 2008; 34: 65-73.
  32. Aleksandrov A.V., Gontar' I.P., Alekhina I.Yu., Zborovskii A.B. Perspektivy primeneniya antigennykh nanosistem v diagnostike i lechenii vospalitel'nykh revmaticheskikh zabolevanii. Ter arkh 2009; 4: 48-51.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.